Quality of life through therapeutic advances. Pharmaceutical company news: Ipsen N.V.
IPSEN is the Belgian subsidiary of the independent European pharmaceutical company Beaufour Ipsen, founded in 1929 by Dr. Henri Beaufour. With an expanding international presence, the group invests almost 20% of group turnover in research and development of high technology ethical products. Beaufour Ipsen R & D's fundamental goal is quality of life for patients with a special emphasis on homeostatic regulation, achieving the optimal efficacy versus tolerance ratio.
D018931:Antineoplastic Agents, Hormonal / Q000737:chemistry / Q000627:therapeutic use; D015195:Drug Design; D004345:Drug Industry; D005060:Europe; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life; D017329:Triptorelin Pamoate / Q000737:chemistry / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D017329:Triptorelin Pamoate